Technical Analysis for IFRX - InflaRx N.V.
|Grade||Last Price||% Change||Price Change|
IFRX closed down 4.0 percent on Thursday, July 19, 2018, on 13 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
|Weak or Absent||N/A||Flat||Up|
|See historical IFRX trend table...|
|Date||Alert Name||Type||% Chg|
|Jul 19||Fell Below 50 DMA||Bearish||0.00%|
|Jul 19||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
|Jul 19||Upper Bollinger Band Walk||Strength||0.00%|
|Jul 19||Inside Day||Range Contraction||0.00%|
|Jul 19||Upper Bollinger Band Touch||Strength||0.00%|
|Jul 18||Shooting Star Candlestick||Bearish||-4.00%|
|Jul 18||Crossed Above 50 DMA||Bullish||-4.00%|
|Jul 18||Expansion Pivot Buy Setup||Bullish Swing Setup||-4.00%|
|Jul 18||Wide Range Bar||Range Expansion||-4.00%|
|Jul 18||Multiple of Ten Bearish||Other||-4.00%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more IFRX news...
|52 Week High||42.83|
|52 Week Low||14.47|
|200-Day Moving Average||0.0|
|50-Day Moving Average||33.721|
|20-Day Moving Average||31.4345|
|10-Day Moving Average||32.475|
|Average True Range||2.7922|
|Chandelier Exit (Long, 3 ATRs )||31.7534|
|Chandelier Exit (Short, 3 ATRs )||36.7166|
|Upper Bollinger Band||34.693|
|Lower Bollinger Band||28.176|
|Percent B (%b)||0.83|
|MACD Signal Line||-0.5308|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||36.60|
|Resistance 3 (R3)||36.93||36.27||36.10|
|Resistance 2 (R2)||36.27||35.50||36.10||35.93|
|Resistance 1 (R1)||34.93||35.03||34.60||34.60||35.77|
|Support 1 (S1)||32.93||33.50||32.60||32.60||31.43|
|Support 2 (S2)||32.27||33.03||32.10||31.27|
|Support 3 (S3)||30.93||32.27||31.10|
|Support 4 (S4)||30.60|